Community Update: Novartis development of Votoplam in HD: INVEST-HD Phase 3 trial information now available

Teva Pharmaceuticals’ Austedo (deutetrabenazine) and its extended-release formulation, Austedo XR — approved to treat chorea, or involuntary movements, in people with Huntington’s disease — have funct